Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease
- PMID: 20556443
- DOI: 10.1007/s00702-010-0434-3
Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease
Abstract
The staging of Lewy-related pathology in sporadic Parkinson's disease (PD) reveals that many brain nuclei are affected in PD during different stages, except the ventral tegmental area (VTA), which is close related to the substantia nigra (SN) and enriched in dopamine (DA) neurons. Why DA neurons are selectively degenerated in the SN of PD is far from known. In the present study, we observed that the number of tyrosine hydroxylase immunoreactive neurons decreased and iron-staining positive cells increased in the SN, but not in the VTA, in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated PD mice. Increased expression of divalent metal transporter 1 and decreased expression of ferroportin 1 might associate with this increased nigral iron levels. Lipofuscin granular aggregations and upregulation of alpha-synuclein (α-synuclein) were also observed only in the SN. These results suggest that increased iron levels associate with the selective degeneration of DA neurons in the SN. The intracellular regulation mechanisms for the iron transporters may be different in the SN and VTA under the same conditions. Moreover, the lipofuscin granular aggregations and upregulation of α-synuclein were also involved in the selective degeneration of dopaminergic neurons in the SN.
Similar articles
-
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x. Acta Neuropathol Commun. 2017. PMID: 28143577 Free PMC article.
-
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.Neurobiol Dis. 2006 Sep;23(3):522-32. doi: 10.1016/j.nbd.2006.04.007. Epub 2006 Jun 30. Neurobiol Dis. 2006. PMID: 16806952
-
Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.Gene. 2018 Jun 30;661:189-195. doi: 10.1016/j.gene.2018.03.086. Epub 2018 Mar 29. Gene. 2018. PMID: 29604467
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?J Neural Transm Suppl. 2003;(65):73-88. doi: 10.1007/978-3-7091-0643-3_5. J Neural Transm Suppl. 2003. PMID: 12946050 Review.
Cited by
-
Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.iScience. 2020 Jul 24;23(7):101284. doi: 10.1016/j.isci.2020.101284. Epub 2020 Jun 19. iScience. 2020. PMID: 32623334 Free PMC article.
-
Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.Mol Neurobiol. 2018 Jan;55(1):804-821. doi: 10.1007/s12035-016-0328-y. Epub 2017 Jan 6. Mol Neurobiol. 2018. PMID: 28062948
-
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis.Cells. 2022 Nov 25;11(23):3768. doi: 10.3390/cells11233768. Cells. 2022. PMID: 36497029 Free PMC article. Review.
-
Longitudinal Development of Brain Iron Is Linked to Cognition in Youth.J Neurosci. 2020 Feb 26;40(9):1810-1818. doi: 10.1523/JNEUROSCI.2434-19.2020. Epub 2020 Jan 27. J Neurosci. 2020. PMID: 31988059 Free PMC article.
-
Iron accumulation in the ventral tegmental area in Parkinson's disease.Front Aging Neurosci. 2023 Jun 28;15:1187684. doi: 10.3389/fnagi.2023.1187684. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37448687 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical